## Abstract Insulin‐like growth factor binding protein‐3 (IGFBP‐3) is postulated to be a mediator of growth suppression signals. Here, we examined the methylation status of __IGFBP‐3__ to correlate to clinicopathological factors in human cancers. The methylation status of __IGFBP‐3__ was determined
Isolation and characterization of the zebrafishDanio rerioinsulin-like growth factor binding protein-3 promoter region
✍ Scribed by Ming Jun CHOU; Jian Chyi CHEN; Jyh Yih CHEN; Hong Yi GONG; Li Tzu LI; Tzou Chi HUANG; Jen Leih WU; Ching Ming KUO
- Book ID
- 108993786
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 532 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0919-9268
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Recent epidemiological studies have shown that high serum levels of insulin‐like growth factor‐I (IGF‐I) are associated with an increased risk of lung, colon, breast and prostate cancer. Since very few studies have addressed the role of serum levels of IGF‐I in the development of pancre
## Abstract We investigated whether circulating insulin‐like growth factor‐I (IGF‐I) and insulin‐like growth factor binding protein‐3 (IGFBP‐3) levels are associated with the risk of fibrocystic breast conditions (FBC), in a case‐control study nested within a randomized trial of breast self‐examina